[On the behavior of minute-ventilation, alveolar ventilation, alveolar ventilation-minute ventilation times 100, functional dead space, circulatory output, pulmonary diffusion, alveolar pCO 2, arterial HbO 2 and pCO 2 in patients with chronic bronchopneumopathy during induced pharmacodynamic action of nicotinic acid].
D000328:Adult; D000368:Aged; D001784:Blood Gas Analysis; D002245:Carbon Dioxide / Q000097:blood; D002908:Chronic Disease; D005260:Female; D006801:Humans; D008168:Lung / Q000503:physiopathology; D008171:Lung Diseases / Q000503:physiopathology*; D008297:Male; D008875:Middle Aged; D009539:Nicotinic Acids / Q000494:pharmacology*; D010092:Oximetry; D011650:Pulmonary Alveoli / Q000503:physiopathology; D011652:Pulmonary Circulation; D012129:Respiratory Function Tests
D009539:Nicotinic Acids; D002245:Carbon Dioxide
Sul comportamento della ventilazione-minuto, ventilazione alveolare, ventilazione alveolare-ventilazione minuto times 100, spazio morto funzionale, portata circolatoria, diffusione polmonare, pCO 2 alveolare, HbO 2 e pCO 2 arteriosa in soggetti broncopneumopatici cronici durante azione farmacodinamica indotta dall'acido nicotinico.